Quantification of pregabalin using hydrophilic interaction hplc-high-resolution ms in postmortem human samples: Eighteen case reports

Journal of Analytical Toxicology

Volumn 38, Issue 3, 2014, Pages 143-148

  Priez barallon, Cédric ^a   Carlier, Jérémy ^a   Boyer, Baptiste ^b   Benslima, Mounir ^c   Fanton, Laurent ^d   Mazoyer, Cédric ^a   Gaillard, Yvan ^a  

^a Laboratoire LAT LUMTOX   (France)

^b UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^c NÎMES UNIVERSITY HOSPITAL   (France)

^d UNIVERSITÉ LYON 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PREGABALIN;

ADULT; AGED; ARTICLE; AUTOPSY; CAUSE OF DEATH; CLINICAL ARTICLE; DRUG CONCENTRATION; DRUG OVERDOSE; DRUG URINE LEVEL; FEMALE; HUMAN; HYDROPHILIC INTERACTION CHROMATOGRAPHY; LIMIT OF QUANTITATION; MALE; MASS SPECTROMETRY; MIDDLE AGED; PRECIPITATION; PROCEDURES; SENSITIVITY ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; AUTOPSY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG OVERDOSE; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; MALE; MASS SPECTROMETRY; MIDDLE AGED; REPRODUCIBILITY OF RESULTS;

EID: 84896099184     PISSN: 01464760     EISSN: 19452403     Source Type: Journal    
DOI: 10.1093/jat/bku004     Document Type: Article

References (36)

1. Vidal, L. (2007) Le dictionnaire Vidal®, 83rd edition. Vidal, Issy-les-Moulineaux, France.
2. Sills, G.J. (2006) The mechanisms of action of gabapentin and pregabalin. Current Opinion in Pharmacology, 6, 108-113.
3. Fink, K., Dooley, D.J., Meder, W.P., Suman-Chauhan, N., Duffy, S., Clusmann, H. et al. (2002) Inhibition of neuronal Ca(2+) influx by gabapentin and pregabalin in the human neocortex. Neuropharmacology, 42, 229-236.
4. Ben-Menachem, E. (2004) Pregabalin pharmacology and its relevance to clinical practice. Epilepsia, 45(Suppl 6), 13-18.
5. Chalabianloo, F., Schjott, J. (2009) Pregabalin and its potential for abuse. Tidsskr Nor Laegeforen, 129, 186-187.
6. Schwan, S., Sundstrom, A., Stjernberg, E., Hallberg, E., Hallberg, P. (2010) A signal for an abuse liability for pregabalin-results from the Swedish spontaneous adverse drug reaction reporting system. European Journal of Clinical Pharmacology, 66, 947-953.
7. Gahr, M., Freudenmann, R.W., Hiemke, C., Kolle, M.A., Schonfeldt- Lecuona, C. (2013) Pregabalin abuse and dependence in Germany: results from a database query. European Journal of Clinical Pharmacology, 69, 1335-1342.
8. Oulis, P., Konstantakopoulos, G. (2010) Pregabalin in the treatment of alcohol and benzodiazepines dependence. CNS Neuroscience and Therapeutics, 16, 45-50.
9. Gajraj, N.M. (2007) Pregabalin: its pharmacology and use in pain management. Anesthesia and Analgesia, 105, 1805-1815.
10. French, J.A., Kugler, A.R., Robbins, J.L., Knapp, L.E., Garofalo, E.A. (2003) Dose-response trial of pregabalin adjunctive therapy in patients with partial seizures. Neurology, 60, 1631-1637.
11. Zaccara, G., Gangemi, P., Perucca, P., Specchio, L. (2011) The adverse event profile of pregabalin: a systematic review and meta-analysis of randomized controlled trials. Epilepsia, 52, 826-836.
12. Braga, A.J., Chidley, K. (2007) Self-poisoning with lamotrigine and pregabalin. Anaesthesia, 62, 524-527.
13. Spiller, H.A., Bratcher, R., Griffith, J.R. (2008) Pregabalin overdose with benign outcome. Clinical Toxicology, 46, 917.
14. Wood, D.M., Berry, D.J., Glover, G., Eastwood, J., Dargan, P.I. (2010) Significant pregabalin toxicity managed with supportive care alone. Journal of Medical Toxicology, 6, 435-437.
15. Aksakal, E., Bakirci, E.M., Emet, M., Uzkeser, M. (2012) Complete atrioventricular block due to overdose of pregabalin. American Journal of Emergency Medicine, 30, 2101. e1-4.
16. Button, J., Berry, D., Holt, D. (2010) Two fatalities involving pregabalin. Toxichem Krimtech, 77, 247-248.
17. Mudiam,M.K., Chauhan, A., Jain, R., Ch, R., Fatima, G., Malhotra, E. et al. (2012) Development, validation and comparison of two microextraction techniques for the rapid and sensitive determination of pregabalin in urine and pharmaceutical formulations after ethyl chloroformate derivatization followed by gas chromatography-mass spectrometric analysis. Journal of Pharmaceutical and Biomedical Analysis, 70, 310-319.
18. Nirogi, R., Kandikere, V., Mudigonda, K., Komarneni, P., Aleti, R. (2009) Liquid chromatography atmospheric pressure chemical ionization tandem mass spectrometry method for the quantification of pregabalin in human plasma. Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences, 877, 3899-3906.
19. Oertel, R., Arenz, N., Pietsch, J., Kirch, W. (2009) Simultaneous determination of three anticonvulsants using hydrophilic interaction LC-MS. Journal of Separation Science, 32, 238-243.
20. Quinones, L., Sasso, J., Tamayo, E., Catalan, J., Gonzalez, J.P., Escala, M. et al. (2010) A comparative bioavailability study of two formulations of pregabalin in healthy Chilean volunteers. Therapeutic Advances in Chronic Disease, 1, 141-148.
21. Heltsley, R., Depriest, A., Black, D.L., Robert, T., Caplan, Y.H., Cone, E.J. (2011) Urine drug testing of chronic pain patients. IV. Prevalence of gabapentin and pregabalin. Journal of Analytical Toxicology, 35, 357-359.
22. Dahl, S.R., Olsen, K.M., Strand, D.H. (2012) Determination of gammahydroxybutyrate (GHB), beta-hydroxybutyrate (BHB), pregabalin, 1,4-butane-diol (1,4BD) and gamma-butyrolactone (GBL) in whole blood and urine samples by UPLC-MSMS. Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences, 885-886, 37-42.
23. Collins, J.A., Janis, G.C. (2012) Analysis of selected anticonvulsants by high performance liquid chromatography-tandem mass spectrometry. Methods in Molecular Biology, 902, 201-209.
24. Chahbouni, A., Sinjewel, A., den Burger, J.C., Vos, R.M., Wilhelm, A.J., Veldkamp, A.I. et al. (2013) Rapid quantification of gabapentin, pregabalin, and vigabatrin in human serum by ultraperformance liquid chromatography with mass-spectrometric detection. Therapeutic Drug Monitoring, 35, 48-53.
25. Vermeij, T.A., Edelbroek, P.M. (2004) Simultaneous highperformance liquid chromatographic analysis of pregabalin, gabapentin and vigabatrin in human serum by precolumn derivatization with o-phtaldialdehyde and fluorescence detection. Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences, 810, 297-303.
26. Shah, V.P., Midha, K.K., Dighe, S., McGilveray, I.J., Skelly, J.P., Yacobi, A. et al. (1991) Analytical methods validation: bioavailability, bioequivalence and pharmacokinetic studies. Conference report. European Journal of Drug Metabolism and Pharmacokinetics, 16, 249-255.
27. Polettini, A. (2006) Applications of LC-MS in toxicology, 1st edition. Pharmaceutical Press, London, United Kingdom.
28. Bevalot, F., Gaillard, Y., Lemeur, C. (2003) Utilisation de macrocommandes pour l'optimisation de l'exploitation des chrommatogrammes de depistages systématiques obtenus en GC-MS. In the 11th meeting of the SocieteFranc aise de Toxicologie Analytique, Dinard, France.
29. Gaillard, Y., Pepin, G. (1997) Use of high-performance liquid chromatography with photodiode-array UV detection for the creation of a 600-compound library. Application to Forensic Toxicology. Journal of Chromatography A, 763, 149-163.
30. Chatenay, C., Bevalot, F., Gaillard, Y. (2009) Use of UPLC-PDA/MS in systematic toxicological analysis. In the 47th Meeting of The International Association of Forensic Toxicologists, Genova, Switzerland.
31. Sauvage, F.L., Saint-Marcoux, F., Duretz, B., Deporte, D., Lachatre, G., Marquet, P. (2006) Screening of drugs and toxic compounds with liquid chromatography-linear ion trap tandem mass spectrometry. Clinical Chemistry, 52, 1735-1742.
32. Sauvage, F.L., Gaulier, J.M., Lachatre, G., Marquet, P. (2008) Pitfalls and prevention strategies for liquid chromatography-tandem mass spectrometry in the selected reaction-monitoring mode for drug analysis. Clinical Chemistry, 54, 1519-1527.
33. Berry, D., Millington, C. (2005) Analysis of pregabalin at therapeutic concentrations in human plasma/serum by reversed-phase HPLC. Therapeutic Drug Monitoring, 27, 451-456.
34. Schulz, M., Iwersen-Bergmann, S., Andresen, H., Schmoldt, A. (2012) Therapeutic and toxic blood concentrations of nearly 1,000 drugs and other xenobiotics. Critical Care, 16, R136.
35. Schulze-Bonhage, A. (2013) Pharmacokinetic and pharmacodynamic profile of pregabalin and its role in the treatment of epilepsy. Expert Opinion on Drug Metabolism and Toxicology, 9, 105-115.
36. Miljevic, C., Crnobaric, C., Nikolic, S., Lecic-Tosevski, D. (2012) A case of pregabalin intoxication. Psychiatrike, 23, 162-165.